Global cord blood corporation announces receipt of blue ocean petition

Hong kong , may 10, 2022 /prnewswire/ -- global cord blood corporation (nyse: co, "gcbc" or the "company"), china's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, announced today that the company has received a copy of a petition that was filed with the grand court of the cayman islands by blue ocean structure investment company limited ("blue ocean"). the company is taking legal advice in response to blue ocean's petition and will make further announcements as appropriate in due course.
CO Ratings Summary
CO Quant Ranking